MHRA Publishes Marketing Authorisations Granted in 1 – 14 February 2023 MHRA Publishes Marketing Authorisations Granted in 1 – 14 February 2023 MHRA granted one OTC licence during 1 – 14... MHRA Publishes Marketing Authorisations Granted in 1 – 14 February 2023
EMA HMPC Launches Calls for Submission of Scientific Data EMA HMPC Calls for Submission of Scientific Data The European Medicines Agency’s (EMA) Committee on Herbal Medicinal Products (HMPC) has... EMA HMPC Launches Calls for Submission of Scientific Data
PAGB Reclassification Workshops PAGB Reclassification Workshops PAGB’s first reclassification guidance: How to identify a reclassification candidate and prepare for the... PAGB Reclassification Workshops
EMA HMPC Meeting Report – January 2023 EMA HMPC Meeting Report – January 2023 EMA’s Committee on Herbal Medicinal Products (HMPC) has published the report from their... EMA HMPC Meeting Report – January 2023
MHRA Publishes Marketing Authorisations Granted 15 – 31 January 2023 MHRA Publishes Marketing Authorisations Granted 15 – 31 January 2023 MHRA granted five OTC licences between 15 – 31 January... MHRA Publishes Marketing Authorisations Granted 15 – 31 January 2023
CMDh January 2023 Meeting – Report CMDh January 2023 Meeting – Report The Co-ordination group for Mutual recognition and Decentralised procedures – human (CMDh) has published... CMDh January 2023 Meeting – Report
MHRA – December 2022 Licensing Time-based Performance Measures Published MHRA – December 2022 Licensing Time-based Performance Measures Published MHRA publish data on the expected time taken to process and... MHRA – December 2022 Licensing Time-based Performance Measures Published
Use of CTIS Becomes Mandatory for New Clinical Trial Applications in the EU Use of CTIS Becomes Mandatory for New Clinical Trial Applications in the EU The Clinical Trials Information System (CTIS) was... Use of CTIS Becomes Mandatory for New Clinical Trial Applications in the EU
MHRA Consultation on Proposals to Increase Statutory Fees – Government Response MHRA Consultation on Proposals to Increase Statutory Fees – Government Response The government response to consultation on proposals for changes... MHRA Consultation on Proposals to Increase Statutory Fees – Government Response
EU IDMP Implementation Guide Chapter 7 Update Released EU IDMP Implementation Guide Chapter 7 Update Released European Medicines Agency (EMA) has released the updated version of the EU... EU IDMP Implementation Guide Chapter 7 Update Released
MHRA Public Assessment Reports MHRA Public Assessment Reports MHRA has published the Public Assessment Reports (PARs) for Voltarol 140 mg Medicated Plaster (Diclofenac sodium),... MHRA Public Assessment Reports
PAGB Reclassification Workshop – Afternoon Session Added PAGB Reclassification Workshop – Afternoon Session Added PAGB’s first reclassification guidance: How to identify a reclassification candidate... PAGB Reclassification Workshop – Afternoon Session Added
